28 April 2018 Breast tumor hemodynamic response during a breath-hold as a biomarker to predict chemotherapeutic efficacy: preclinical study
Author Affiliations +
Abstract
Continuous wave diffuse optical tomographic/spectroscopic system does not provide absolute concentrations of chromophores in tissue and monitor only the changes of chromophore concentration. Therefore, it requires a perturbation of physiological signals, such as blood flow and oxygenation. In that sense, a few groups reported that monitoring a relative hemodynamic change during a breast tissue compression or a breath-hold to a patient can provide good contrast between tumor and nontumor. However, no longitudinal study reports the utilization of a breath-hold to predict tumor response during chemotherapy. A continuous wave near-infrared spectroscopy was employed to monitor hemodynamics in rat breast tumor during a hyperoxic to normoxic inhalational gas intervention to mimic a breath-hold during tumor growth and chemotherapy. The reduced oxyhemoglobin concentration during inhalational gas intervention correlated well with tumor growth, and it responded one day earlier than the change of tumor volume after chemotherapy. In conclusion, monitoring tumor hemodynamics during a breath-hold may serve as a biomarker to predict chemotherapeutic efficacy of tumor.
© 2018 Society of Photo-Optical Instrumentation Engineers (SPIE)
Songhyun Lee, Songhyun Lee, Jae Gwan Kim, Jae Gwan Kim, } "Breast tumor hemodynamic response during a breath-hold as a biomarker to predict chemotherapeutic efficacy: preclinical study," Journal of Biomedical Optics 23(4), 048001 (28 April 2018). https://doi.org/10.1117/1.JBO.23.4.048001 . Submission: Received: 21 November 2017; Accepted: 13 April 2018
Received: 21 November 2017; Accepted: 13 April 2018; Published: 28 April 2018
JOURNAL ARTICLE
5 PAGES


SHARE
RELATED CONTENT


Back to Top